EBOS Group Expands Market Presence with New Securities Quotation

EBOS Group Limited ( (AU:EBO) ) just unveiled an announcement.

EBOS Group Limited has announced the quotation of 19,994 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective from September 4, 2025. This move is part of the company’s strategy to enhance its market presence and liquidity, potentially impacting its operational capabilities and offering new opportunities for stakeholders.

The most recent analyst rating on (AU:EBO) stock is a Buy with a A$34.82 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.

More about EBOS Group Limited

EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a range of products and services including wholesale and distribution of healthcare, medical, and pharmaceutical products. The company focuses on serving markets in Australia and New Zealand.

Average Trading Volume: 105,511

Technical Sentiment Signal: Sell

Current Market Cap: A$6.08B

See more insights into EBO stock on TipRanks’ Stock Analysis page.